Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma.

Nghiem PT, Bhatia S, Lipson EJ, Kudchadkar RR, Miller NJ, Annamalai L, Berry S, Chartash EK, Daud A, Fling SP, Friedlander PA, Kluger HM, Kohrt HE, Lundgren L, Margolin K, Mitchell A, Olencki T, Pardoll DM, Reddy SA, Shantha EM, Sharfman WH, Sharon E, Shemanski LR, Shinohara MM, Sunshine JC, Taube JM, Thompson JA, Townson SM, Yearley JH, Topalian SL, Cheever MA.

N Engl J Med. 2016 Jun 30;374(26):2542-52. doi: 10.1056/NEJMoa1603702. Epub 2016 Apr 19.

2.

Vaccine responses in patients with rheumatoid arthritis treated with certolizumab pegol: results from a single-blind randomized phase IV trial.

Kivitz AJ, Schechtman J, Texter M, Fichtner A, de Longueville M, Chartash EK.

J Rheumatol. 2014 Apr;41(4):648-57. doi: 10.3899/jrheum.130945. Epub 2014 Mar 1.

3.

Safety and efficacy of ABT-874, a fully human interleukin 12/23 monoclonal antibody, in the treatment of moderate to severe chronic plaque psoriasis: results of a randomized, placebo-controlled, phase 2 trial.

Kimball AB, Gordon KB, Langley RG, Menter A, Chartash EK, Valdes J; ABT-874 Psoriasis Study Investigators.

Arch Dermatol. 2008 Feb;144(2):200-7. doi: 10.1001/archdermatol.2007.63.

PMID:
18283176
5.

Long term efficacy and safety of adalimumab plus methotrexate in patients with rheumatoid arthritis: ARMADA 4 year extended study.

Weinblatt ME, Keystone EC, Furst DE, Kavanaugh AF, Chartash EK, Segurado OG.

Ann Rheum Dis. 2006 Jun;65(6):753-9. Epub 2005 Nov 24.

7.
8.

Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: a pilot study.

Weisman MH, Moreland LW, Furst DE, Weinblatt ME, Keystone EC, Paulus HE, Teoh LS, Velagapudi RB, Noertersheuser PA, Granneman GR, Fischkoff SA, Chartash EK.

Clin Ther. 2003 Jun;25(6):1700-21.

PMID:
12860493
9.

Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial.

Weinblatt ME, Keystone EC, Furst DE, Moreland LW, Weisman MH, Birbara CA, Teoh LA, Fischkoff SA, Chartash EK.

Arthritis Rheum. 2003 Jan;48(1):35-45. Erratum in: Arthritis Rheum. 2003 Mar;48(3):855.

10.

Clonal expansion is a characteristic feature of the B-cell repetoire of patients with rheumatoid arthritis.

Itoh K, Patki V, Furie RA, Chartash EK, Jain RI, Lane L, Asnis SE, Chiorazzi N.

Arthritis Res. 2000;2(1):50-8.

11.

A role for the polymorphism at position 247 of the beta2-glycoprotein I gene in the generation of anti-beta2-glycoprotein I antibodies in the antiphospholipid syndrome.

Hirose N, Williams R, Alberts AR, Furie RA, Chartash EK, Jain RI, Sison C, Lahita RG, Merrill JT, Cucurull E, Gharavi AE, Sammaritano LR, Salmon JE, Hashimoto S, Sawada T, Chu CC, Gregersen PK, Chiorazzi N.

Arthritis Rheum. 1999 Aug;42(8):1655-61.

12.

Reversible monocular blindness complicating Churg-Strauss syndrome.

Alberts AR, Lasonde R, Ackerman KR, Chartash EK, Susin M, Furie RA.

J Rheumatol. 1994 Feb;21(2):363-5.

PMID:
8182653
13.

Cardiac manifestations of the antiphospholipid syndrome.

Kaplan SD, Chartash EK, Pizzarello RA, Furie RA.

Am Heart J. 1992 Nov;124(5):1331-8. Review.

PMID:
1442504
14.

Septic subdeltoid bursitis.

Chartash EK, Good PK, Gould ES, Furie RA.

Semin Arthritis Rheum. 1992 Aug;22(1):25-9. Review.

PMID:
1411579
15.

L-tryptophan induced eosinophilia-myalgia syndrome.

Chartash EK, Given WP, Vishnubhakat SM, Susin M, Coffey EL Jr, Farmer PM, Albanese JM, Kaplan MH, Furie RA.

J Rheumatol. 1990 Nov;17(11):1527-33.

PMID:
2273498
16.
17.

T helper cell-induced CD23 (BLAST-2) expression: an activation marker for the high density fraction of human B cells.

Jover JA, Chartash EK, Kushner B, Friedman SM, Crow MK.

Clin Immunol Immunopathol. 1989 Oct;53(1):99-112.

PMID:
2527658
18.
19.

Aortic insufficiency and mitral regurgitation in patients with systemic lupus erythematosus and the antiphospholipid syndrome.

Chartash EK, Lans DM, Paget SA, Qamar T, Lockshin MD.

Am J Med. 1989 Apr;86(4):407-12.

PMID:
2929627
20.

Tendon rupture in systemic lupus erythematosus.

Furie RA, Chartash EK.

Semin Arthritis Rheum. 1988 Nov;18(2):127-33. Review.

PMID:
3064304
21.

Direct human T helper cell-induced B cell activation is not mediated by inositol lipid hydrolysis.

Chartash EK, Imai A, Gershengorn MC, Crow MK, Friedman SM.

J Immunol. 1988 Mar 15;140(6):1974-81.

PMID:
2831275
22.

Antigen-specific, MHC nonrestricted T helper cell-induced B cell activation.

Friedman SM, Jover JA, Chartash EK, Crow MK.

J Exp Med. 1986 Nov 1;164(5):1773-8.

Supplemental Content

Loading ...
Support Center